C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) A61K 39/395 (2006.01) C07K 7/04 (2006.01) C07K 7/08 (2006.01) C07K 16/46 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2466592
The invention relates to the modification of antibodies reactive to human tumor necrosis factor alpha (TNF alpha) to result in anti-TNF alpha antibodies that are substantially non-immunogenic or less immunogenic than any non- modified parental antibody when used in vivo. The invention relates also to peptide molecules comprising T-cell epitopes of the V-regions of the parental antibody which are modified by amino acid alteration in order to reduce or eliminate said T-cell epitopes.
L'invention concerne la modification d'anticorps réactifs au facteur de nécrose tumorale alpha (TNF alpha) en vue d'obtenir des anticorps anti-TNF-alpha sensiblement non immunogènes ou moins immunogènes que n'importe quel anticorps parental non modifié lorsqu'il est utilisé <i>in vivo</i>. L'invention concerne également des molécules peptidiques comprenant des épithopes de lymphocytes T des zones V de l'anticorps parental modifiées par altération amino acide en vue de réduire ou d'éliminer les épithopes de lymphocytes T.
Baker Matthew
Carr Francis J.
Hellendoorn Koen
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Modified anti-tnf alpha antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified anti-tnf alpha antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified anti-tnf alpha antibody will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1972749